The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating ...
The FDA is eliminating “unnecessary testing” on animals, according to Commissioner Marty Makary. He joined “Katie Pavlich ...
Humane World for Animals and Humane World Action Fund encouraged by newly proposed guidance to advance non-animal method ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...
The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing as the standard.
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...